API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercebiotech.com/biotech/ironwood-spies-new-frontier-1b-drug-exploratory-rare-disease-trial
https://www.reuters.com/business/healthcare-pharmaceuticals/ironwood-says-bowel-disease-treatment-meets-main-goal-late-stage-trial-2024-02-29/
https://www.globenewswire.com/news-release/2023/03/13/2625677/0/en/VectivBio-and-Asahi-Kasei-Pharma-Announce-the-Start-of-a-Phase-1-Study-of-Apraglutide-in-Japan.html
https://www.globenewswire.com/news-release/2022/10/13/2533698/0/en/VectivBio-Reports-Positive-Interim-Clinical-Data-from-STARS-Nutrition-a-Phase-2-Study-Investigating-Apraglutide-in-Short-Bowel-Syndrome-with-Intestinal-Failure-Patients-SBS-IF-with.html
https://www.globenewswire.com/news-release/2022/03/23/2408410/0/en/VectivBio-Presents-Preclinical-Data-Supporting-Apraglutide-for-Treatment-of-Acute-Graft-Versus-Host-Disease-at-the-48th-Annual-Meeting-of-the-European-Society-for-Blood-and-Marrow-.html
https://www.globenewswire.com/news-release/2021/10/20/2317254/0/en/VectivBio-Announces-Successful-Opening-of-US-IND-for-Apraglutide-for-Acute-Graft-Versus-Host-Disease.html
https://www.globenewswire.com/news-release/2021/06/24/2252256/0/en/Hyloris-Successfully-Renegotiates-License-Agreements-for-Lead-Products-with-the-Alter-Pharma-Group.html
https://www.globenewswire.com/news-release/2021/06/24/2252470/0/en/VectivBio-Receives-FDA-Orphan-Drug-Designation-for-Apraglutide-for-Acute-Graft-Versus-Host-Disease.html